tiprankstipranks
Trending News
More News >
China Medical System Holdings Ltd. (CHSYF)
OTHER OTC:CHSYF
US Market

China Medical System Holdings (CHSYF) Ratios

Compare
12 Followers

China Medical System Holdings Ratios

CHSYF's free cash flow for Q2 2024 was ¥0.75. For the 2024 fiscal year, CHSYF's free cash flow was decreased by ¥ and operating cash flow was ¥0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
4.29 3.07 3.55 5.46 2.30
Quick Ratio
3.98 2.90 3.32 5.04 2.03
Cash Ratio
2.10 1.52 1.63 2.93 0.88
Solvency Ratio
1.20 1.16 1.09 1.71 1.31
Operating Cash Flow Ratio
1.22 1.24 1.20 2.95 1.65
Short-Term Operating Cash Flow Coverage
1.97 1.99 2.26 269.20K 3.68
Net Current Asset Value
¥ 6.62B¥ 5.81B¥ 4.42B¥ 3.38B¥ 1.90B
Leverage Ratios
Debt-to-Assets Ratio
0.07 0.10 0.11 0.05 0.06
Debt-to-Equity Ratio
0.08 0.12 0.13 0.05 0.08
Debt-to-Capital Ratio
0.08 0.11 0.12 0.05 0.07
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.04 0.05 0.00
Financial Leverage Ratio
1.14 1.22 1.24 1.15 1.18
Debt Service Coverage Ratio
1.85 1.84 2.89 101.40 2.95
Interest Coverage Ratio
58.65 81.91 136.75 119.25 46.87
Debt to Market Cap
0.04 0.07 0.06 0.03 0.03
Interest Debt Per Share
0.55 0.76 0.71 0.25 0.31
Net Debt to EBITDA
-1.03 -0.67 -0.45 -0.68 -0.24
Profitability Margins
Gross Profit Margin
76.24%76.89%74.93%73.92%74.85%
EBIT Margin
33.85%41.66%41.80%40.94%41.89%
EBITDA Margin
36.47%42.07%44.44%43.94%45.24%
Operating Profit Margin
33.85%43.94%46.37%47.25%43.41%
Pretax Profit Margin
35.86%41.12%41.46%40.54%40.96%
Net Profit Margin
29.96%35.62%36.19%36.43%32.28%
Continuous Operations Profit Margin
29.76%35.80%36.29%36.79%32.20%
Net Income Per EBT
83.55%86.61%87.29%89.86%78.82%
EBT Per EBIT
105.93%93.59%89.41%85.81%94.36%
Return on Assets (ROA)
13.54%18.36%19.09%19.92%17.55%
Return on Equity (ROE)
15.47%22.34%23.66%22.93%20.70%
Return on Capital Employed (ROCE)
17.30%27.03%28.16%27.84%27.40%
Return on Invested Capital (ROIC)
13.27%20.99%22.79%25.25%20.07%
Return on Tangible Assets
17.19%25.59%27.16%29.36%26.76%
Earnings Yield
7.92%12.25%11.53%14.05%7.89%
Efficiency Ratios
Receivables Turnover
4.62 4.49 3.84 4.08 3.87
Payables Turnover
13.44 11.88 14.33 13.44 34.68
Inventory Turnover
2.99 4.43 4.42 4.75 3.75
Fixed Asset Turnover
16.91 18.47 15.30 13.06 7.04
Asset Turnover
0.45 0.52 0.53 0.55 0.54
Working Capital Turnover Ratio
1.26 1.63 1.78 2.29 2.64
Cash Conversion Cycle
174.14 133.01 152.01 139.04 181.03
Days of Sales Outstanding
79.07 81.36 94.97 89.40 94.27
Days of Inventory Outstanding
122.23 82.37 82.52 76.80 97.28
Days of Payables Outstanding
27.16 30.73 25.48 27.16 10.52
Operating Cycle
201.30 163.74 177.49 166.20 191.55
Cash Flow Ratios
Operating Cash Flow Per Share
1.02 1.45 1.01 1.09 1.03
Free Cash Flow Per Share
0.89 1.23 0.94 0.95 0.89
CapEx Per Share
0.13 0.21 0.07 0.14 0.14
Free Cash Flow to Operating Cash Flow
0.87 0.85 0.93 0.87 0.87
Dividend Paid and CapEx Coverage Ratio
1.49 1.97 1.86 2.29 2.20
Capital Expenditure Coverage Ratio
7.87 6.77 13.49 7.88 7.50
Operating Cash Flow Coverage Ratio
1.92 1.96 1.46 4.49 3.58
Operating Cash Flow to Sales Ratio
0.31 0.39 0.30 0.39 0.42
Free Cash Flow Yield
7.21%11.38%8.82%13.05%8.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.62 8.16 8.67 7.12 12.68
Price-to-Sales (P/S) Ratio
3.78 2.91 3.14 2.59 4.09
Price-to-Book (P/B) Ratio
1.95 1.82 2.05 1.63 2.62
Price-to-Free Cash Flow (P/FCF) Ratio
13.87 8.79 11.33 7.66 11.23
Price-to-Operating Cash Flow Ratio
12.11 7.49 10.49 6.69 9.73
Price-to-Earnings Growth (PEG) Ratio
-0.48 0.91 0.44 0.24 1.88
Price-to-Fair Value
1.95 1.82 2.05 1.63 2.62
Enterprise Value Multiple
9.34 6.25 6.61 5.22 8.81
Enterprise Value
EV to EBITDA
9.34 6.25 6.61 5.22 8.81
EV to Sales
3.41 2.63 2.94 2.29 3.99
EV to Free Cash Flow
12.49 7.94 10.61 6.78 10.93
EV to Operating Cash Flow
10.91 6.77 9.82 5.92 9.47
Tangible Book Value Per Share
4.81 3.96 3.30 2.84 2.29
Shareholders’ Equity Per Share
6.33 5.95 5.17 4.46 3.82
Tax and Other Ratios
Effective Tax Rate
0.17 0.13 0.12 0.09 0.21
Revenue Per Share
3.27 3.73 3.38 2.81 2.45
Net Income Per Share
0.98 1.33 1.22 1.02 0.79
Tax Burden
0.84 0.87 0.87 0.90 0.79
Interest Burden
1.06 0.99 0.99 0.99 0.98
Research & Development to Revenue
0.02 0.01 0.01 <0.01 <0.01
SG&A to Revenue
0.08 0.07 0.05 0.04 0.04
Stock-Based Compensation to Revenue
>-0.01 <0.01 <0.01 0.00 0.00
Income Quality
0.87 0.94 0.72 0.96 1.03
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis